HER2/neu Receptor-Targeted Gelatin-Based Nanovectors for Pancreatic Cancer Gene Therapy

HER2/neu Receptor-Targeted Gelatin-Based Nanovectors for Pancreatic Cancer Gene Therapy

Date: 06/14/2007
Time: 10:00 am
Location: 406 Egan
Speaker: Padmaja Magadala, IGERT Nanomedicine Fellow